Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8802 |
High Similarity |
NPD6959 |
Discontinued |
0.8488 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.8457 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.8436 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.8421 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.8343 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.8263 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.8263 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.8258 |
Intermediate Similarity |
NPD8313 |
Approved |
0.8258 |
Intermediate Similarity |
NPD8312 |
Approved |
0.8176 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8118 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.8114 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.8023 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.8012 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8011 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8011 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.8011 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7989 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7978 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7964 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7963 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7958 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7958 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7923 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7877 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7874 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7857 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7857 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7857 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7845 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7842 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7842 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7842 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7842 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7842 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7842 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7842 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7816 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7812 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7812 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7812 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7812 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7791 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7771 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7771 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7751 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7751 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7746 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7744 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7744 |
Intermediate Similarity |
NPD7701 |
Phase 2 |
0.7735 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7735 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.773 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7705 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7701 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.768 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7674 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7665 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.7665 |
Intermediate Similarity |
NPD7874 |
Approved |
0.765 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7644 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7644 |
Intermediate Similarity |
NPD7700 |
Phase 2 |
0.7644 |
Intermediate Similarity |
NPD7699 |
Phase 2 |
0.7626 |
Intermediate Similarity |
NPD7801 |
Approved |
0.7624 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7624 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7607 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7605 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.76 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7596 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.759 |
Intermediate Similarity |
NPD5406 |
Approved |
0.759 |
Intermediate Similarity |
NPD5408 |
Approved |
0.759 |
Intermediate Similarity |
NPD5405 |
Approved |
0.759 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7584 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7579 |
Intermediate Similarity |
NPD6535 |
Approved |
0.7579 |
Intermediate Similarity |
NPD6534 |
Approved |
0.7577 |
Intermediate Similarity |
NPD6823 |
Phase 2 |
0.7545 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7545 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7538 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.7538 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.7515 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7514 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.75 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD8319 |
Approved |
0.75 |
Intermediate Similarity |
NPD8320 |
Phase 1 |
0.7485 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7485 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7471 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7463 |
Intermediate Similarity |
NPD8155 |
Clinical (unspecified phase) |
0.7458 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7447 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7429 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7412 |
Intermediate Similarity |
NPD3750 |
Approved |
0.741 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7403 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7401 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7401 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7399 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7381 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7371 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.736 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7353 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7345 |
Intermediate Similarity |
NPD37 |
Approved |
0.7337 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7326 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7308 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7308 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7302 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7283 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7278 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7278 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7257 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7254 |
Intermediate Similarity |
NPD6213 |
Phase 3 |
0.7254 |
Intermediate Similarity |
NPD6212 |
Phase 3 |
0.7254 |
Intermediate Similarity |
NPD6214 |
Clinical (unspecified phase) |
0.7251 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7238 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7235 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7231 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7222 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7222 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7222 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7209 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7209 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7209 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7186 |
Intermediate Similarity |
NPD943 |
Approved |
0.7178 |
Intermediate Similarity |
NPD1470 |
Approved |
0.7174 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7151 |
Intermediate Similarity |
NPD7177 |
Discontinued |
0.7143 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7135 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7128 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7123 |
Intermediate Similarity |
NPD8059 |
Phase 3 |
0.7123 |
Intermediate Similarity |
NPD8058 |
Clinical (unspecified phase) |
0.712 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7118 |
Intermediate Similarity |
NPD3748 |
Approved |
0.709 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7089 |
Intermediate Similarity |
NPD7654 |
Discontinued |
0.7076 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7071 |
Intermediate Similarity |
NPD8285 |
Discontinued |
0.7062 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7062 |
Intermediate Similarity |
NPD920 |
Approved |
0.7035 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.703 |
Intermediate Similarity |
NPD7211 |
Clinical (unspecified phase) |
0.7021 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7018 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7011 |
Intermediate Similarity |
NPD8166 |
Discontinued |
0.7006 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.6973 |
Remote Similarity |
NPD1247 |
Approved |
0.6973 |
Remote Similarity |
NPD7199 |
Phase 2 |
0.6971 |
Remote Similarity |
NPD2309 |
Approved |
0.6968 |
Remote Similarity |
NPD7893 |
Clinical (unspecified phase) |
0.6964 |
Remote Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.6963 |
Remote Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.6954 |
Remote Similarity |
NPD1243 |
Approved |
0.6949 |
Remote Similarity |
NPD642 |
Clinical (unspecified phase) |
0.6941 |
Remote Similarity |
NPD230 |
Phase 1 |
0.6933 |
Remote Similarity |
NPD1201 |
Approved |
0.6923 |
Remote Similarity |
NPD4287 |
Approved |
0.6923 |
Remote Similarity |
NPD5761 |
Phase 2 |
0.6923 |
Remote Similarity |
NPD5760 |
Phase 2 |
0.6919 |
Remote Similarity |
NPD2799 |
Discontinued |
0.6912 |
Remote Similarity |
NPD7584 |
Approved |
0.6911 |
Remote Similarity |
NPD7685 |
Pre-registration |
0.691 |
Remote Similarity |
NPD6273 |
Approved |
0.6875 |
Remote Similarity |
NPD6190 |
Approved |
0.6869 |
Remote Similarity |
NPD4360 |
Phase 2 |
0.6869 |
Remote Similarity |
NPD4363 |
Phase 3 |
0.6865 |
Remote Similarity |
NPD919 |
Approved |
0.6864 |
Remote Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.6864 |
Remote Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.6864 |
Remote Similarity |
NPD3764 |
Approved |
0.6845 |
Remote Similarity |
NPD4908 |
Phase 1 |
0.6836 |
Remote Similarity |
NPD643 |
Clinical (unspecified phase) |
0.6836 |
Remote Similarity |
NPD3300 |
Phase 2 |
0.6826 |
Remote Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.6809 |
Remote Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.6805 |
Remote Similarity |
NPD3027 |
Phase 3 |
0.6791 |
Remote Similarity |
NPD8127 |
Discontinued |
0.6765 |
Remote Similarity |
NPD2313 |
Discontinued |
0.6762 |
Remote Similarity |
NPD7930 |
Approved |
0.6761 |
Remote Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.6748 |
Remote Similarity |
NPD1651 |
Approved |
0.6729 |
Remote Similarity |
NPD7907 |
Approved |
0.6726 |
Remote Similarity |
NPD2798 |
Approved |
0.6707 |
Remote Similarity |
NPD1283 |
Approved |
0.6701 |
Remote Similarity |
NPD8453 |
Clinical (unspecified phase) |
0.6687 |
Remote Similarity |
NPD3972 |
Approved |
0.6686 |
Remote Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.6686 |
Remote Similarity |
NPD1613 |
Approved |
0.6686 |
Remote Similarity |
NPD2438 |
Suspended |
0.6685 |
Remote Similarity |
NPD6844 |
Discontinued |
0.6683 |
Remote Similarity |
NPD7680 |
Approved |
0.6667 |
Remote Similarity |
NPD6973 |
Clinical (unspecified phase) |
0.6651 |
Remote Similarity |
NPD8366 |
Approved |
0.665
|
Remote Similarity |
NPD7237 |
Clinical (unspecified phase) |